Genovis AB (FRA:5GV) Moat Score: 0/10 (As of Jul. 06, 2026)


FRA:5GV Genovis AB FRA:5GV
93 GF Score
Price €1.84
GF Value €2.57
! 3 Warning Signs
View Full Analysis

What is Genovis AB Moat Score?

Genovis AB has the Moat Score of 0, which implies that the company might have No Moat - No discernible moat.

Genovis AB has

Moat Score is a ranking system developed by GuruFocus to assess a company's ability to sustain a competitive advantage, rated on a scale from 0 to 10. It takes into account key factors such as market leadership, cost advantages, network effects, customer switching costs, and more.

The company's Moat Score is based on these criteria:

1. Market leadership and sustainable market share
2. Network effects and significant customer switching costs
3. Valuable intellectual property and patents
4. Strong brand strength and deep customer loyalty
5. Durable cost advantages (e.g., economies of scale, proprietary technology)
6. Significant regulatory barriers and exclusive licenses
7. Superior distribution network
8. Strong and sustainable pricing power
9. Consistent and impactful innovation and R&D capabilities

Based on the research, GuruFocus believes Genovis AB might have No Moat - No discernible moat.

Genovis AB  (FRA:5GV) Moat Score Explanation

The Moat Score ranges from 0 to 10, with 10 as the highest. GuruFocus divided Moat Score into following 8 categories:

Moat Score Moat Level
10Wide Moat - Exceptionally dominant and durable wide moat
8 - 9Wide Moat - Clear and robust wide moat
7Wide Moat - Entry-level wide moat, clearly possessing durable advantages
6Narrow Moat - Strong narrow moat, clearly distinguishable but not wide
5Narrow Moat - Solid narrow moat
4Narrow Moat - Discernible but modest moat
1 - 3No Moat - Very weak/transient advantages
0No Moat - No discernible moat

Genovis AB Moat Score Related Terms

FRA:5GV
93GF Score
Genovis AB FRA:5GV
Moat Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Genovis AB (FRA:5GV) Overvalued in 2026?

Based on GuruFocus' analysis, Genovis AB stock appears to be undervalued. The current stock price of €1.84 is trading 28.4% below its estimated GF Value™ of €2.57.

Key valuation signals for FRA:5GV:

  • Moat Score: 0
  • GF Value™: €2.57 vs. price of €1.84 (28.4% below fair value)
  • GF Score™: 93/100 with 3 warning signs

No single metric tells the full story. See the FRA:5GV stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Genovis AB Business Description

Other Exchanges GENO:Sweden
Address Kavlinge, Box 4, Lund, SWE, SE-24421
Genovis AB offers customers in the biopharmaceutical and research industries tools that facilitate and save time in the development of new treatment methods and diagnostics. Its enzyme products, known as SmartEnzymes, are used by scientists all over the world, and the product formats facilitate the development and quality control of biological drugs. Its products include Enzyme and Antibodies. Geographically, it operates in Sweden and Rest of the world.
93GF Score

Get the complete analysis for FRA:5GV

Moat Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€1.84
Price
€2.57
GF Value